Basics Erasca, Inc. IPO Date: July 16, 2021 Sector: Healthcare Industry: Biotech Market Cap: $456.71M Activated in VL: True Average Daily Range Avg Daily Range: $0.21 | 3.65% Avg Daily Range (30 D): $0.05 | 3.25% Avg Daily Range (90 D): $0.06 | 3.91% Institutional Daily Volume Avg Daily Volume: .84M Avg Daily Volume (30 D): .71M Avg Daily Volume (90 D): .97M Trade Size Avg Trade Size (Sh.): 135 Avg Trade Size (Sh.) (30 D): 163 Avg Trade Size (Sh.) (90 D): 173 Institutional Trades Total Inst.Trades: 425 Avg Inst. Trade: $1.99M Avg Inst. Trade (30 D): $.75M Avg Inst. Trade (90 D): $1.64M Avg Inst. Trade Volume: .44M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.81M Avg Closing Trade (30 D): $.55M Avg Closing Trade (90 D): $1.2M Avg Closing Volume: 579.79K     News Aug 13, 2025 @ 2:16 AM Erasca Narrows Loss 46% in Fiscal Q2 Source: Na May 29, 2025 @ 12:00 PM Erasca to Present at Upcoming Investor Conferences... Source: Na Jan 31, 2025 @ 1:00 PM Erasca to Present at the Guggenheim Securities SMI... Source: N/A Dec 26, 2024 @ 4:26 PM Oncology in Focus: How Emerging Therapies Are Resh... Source: Prnewswire Nov 5, 2024 @ 1:00 PM Erasca to Present at Upcoming Investor Conferences... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.12 $-.11 $-.09 Diluted EPS $-.12 $-.11 $-.09 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -33.88M $ -30.97M $ -32.23M Operating Income / Loss $ -38.13M $ -35.63M $ -35.71M Cost of Revenue $ $ $ Net Cash Flow $ -4.34M $ 2.74M $ -1.15M PE Ratio